Full metadata record

DC Field Value Language
dc.contributor.authorHan, C.-M.-
dc.contributor.authorPark, K.-S.-
dc.contributor.authorJoung, Y.K.-
dc.date.accessioned2024-01-19T23:30:48Z-
dc.date.available2024-01-19T23:30:48Z-
dc.date.created2021-09-02-
dc.date.issued2018-03-
dc.identifier.issn2093-5552-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/121686-
dc.description.abstractVascular stent is tubular shaped medical device designed to treat occluded circulatory or digestive systems by opening the blocked vascular sites. Originally stents were made of bare metals, such as stainless steel and cobalt?chromium alloys, due to their inherent corrosion resistance and good mechanical properties. Damage of intimal layer during expansion of stent, however, have caused neointimal hyperplasia resulting in in-stent restenosis which is one of main complications of vascular stent treatment. Drug-eluting stents (DESs) were introduced to alleviate this restenosis by local delivery of anti-proliferative drugs to the implanted or inserted site. The DES systems have been developed over the years by making changes in its main component, namely, drug, polymeric coating layer and expandable scaffold. Nevertheless, late thrombosis caused by drugs themselves and polymeric coating layer still remains as a serious problem of DES systems. Numerous studies, therefore, consistently focus on more advanced DES systems to solve the current issues. In this mini review article, we cast an opinion on how to improve the potential of DES system by means of (i) summarizing the history of DES system developed so far and (ii) updating current advances for the future generation of DES system. ? 2017, The Korean Society of Pharmaceutical Sciences and Technology.-
dc.languageEnglish-
dc.publisher한국약제학회-
dc.titleRecent alternative approaches of vascular drug-eluting stents-
dc.typeArticle-
dc.identifier.doi10.1007/s40005-017-0378-9-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJournal of Pharmaceutical Investigation, v.48, no.2, pp.153 - 165-
dc.citation.titleJournal of Pharmaceutical Investigation-
dc.citation.volume48-
dc.citation.number2-
dc.citation.startPage153-
dc.citation.endPage165-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.identifier.kciidART002325054-
dc.identifier.scopusid2-s2.0-85042442008-
dc.type.docTypeReview-
dc.subject.keywordPluseverolimus-
dc.subject.keywordPlusmonocyte chemotactic protein 1-
dc.subject.keywordPlusnitric oxide-
dc.subject.keywordPlusphosphorylcholine-
dc.subject.keywordPlusplatelet endothelial cell adhesion molecule 1-
dc.subject.keywordPlusscatter factor-
dc.subject.keywordPlusvasculotropin-
dc.subject.keywordPluszotarolimus-
dc.subject.keywordPlusantibody response-
dc.subject.keywordPluscell specificity-
dc.subject.keywordPluscytotoxicity-
dc.subject.keywordPlusendothelial progenitor cell-
dc.subject.keywordPlushuman-
dc.subject.keywordPlushydrophobicity-
dc.subject.keywordPlushyperplasia-
dc.subject.keywordPlusin-stent restenosis-
dc.subject.keywordPlusinflammation-
dc.subject.keywordPlusnanofabrication-
dc.subject.keywordPluspriority journal-
dc.subject.keywordPlusReview-
dc.subject.keywordPlusserodiagnosis-
dc.subject.keywordPlusshear stress-
dc.subject.keywordPlusthrombosis-
dc.subject.keywordAuthorAnti-inflammation-
dc.subject.keywordAuthorDrug eluting stent-
dc.subject.keywordAuthorRe-endothelialization-
dc.subject.keywordAuthorRestenosis-
dc.subject.keywordAuthorThrombosis-
dc.subject.keywordAuthorVascular stent-
Appears in Collections:
KIST Article > 2018
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE